KEGG   DRUG: Liraglutide
Entry
D06404                      Drug                                   
Name
Liraglutide (USAN/INN);
Liraglutide (genetical recombination) (JAN);
Victoza (TN)
Product
SAXENDA (A-S Medication Solutions), SAXENDA (Novo Nordisk), VICTOZA (A-S Medication Solutions), VICTOZA (A-S Medication Solutions), VICTOZA (Novo Nordisk)
Formula
C172H265N43O51
Exact mass
3748.9465
Mol weight
3751.202
Sequence
His Ala Glu Gly Thr Phe Thr Ser Asp Val Ser Ser Tyr Leu Glu Gly
Gln Ala Ala Lys Glu Phe Ile Ala Trp Leu Val Arg Gly Arg Gly
(-Glu combined: 20)
  Type
Peptide
Class
Antidiabetic agent
 DG02044  Hypoglycemic agent
  DG01493  GLP-1 receptor agonist
Remark
Therapeutic category: 2499
ATC code: A10BJ02
Product: D06404<JP/US>
Product (mixture): D11567<JP/US>
Efficacy
Antidiabetic, Glucagon-like peptide 1 (GLP-1) receptor agonist
  Disease
Type 2 diabetes mellitus [DS:H00409]
Comment
Human glucagon-like peptide 1 (GLP-1) [CPD:C16048] analog
Adjunctive thrapy to improve glycemic control, with diet and exercise in patients with type II diabetes
Target
GLP1R [HSA:2740] [KO:K04581]
  Pathway
hsa04080  Neuroactive ligand-receptor interaction
hsa04911  Insulin secretion
Interaction
Structure map
map07051  Antidiabetics
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A10 DRUGS USED IN DIABETES
   A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
    A10BJ Glucagon-like peptide-1 (GLP-1) analogues
     A10BJ02 Liraglutide
      D06404  Liraglutide (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
 Anti-Obesity Agents
  Liraglutide
   D06404  Liraglutide (USAN/INN)
 Blood Glucose Regulators
  Antidiabetic Agents
   GLP-1 Receptor Agonist
    Liraglutide
     D06404  Liraglutide (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  24  Hormones
   249  Miscellaneous
    2499  Others
     D06404  Liraglutide (USAN/INN); Liraglutide (genetical recombination) (JAN)
Drug groups [BR:br08330]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   DG01493  GLP-1 receptor agonist
    D06404  Liraglutide
Drug classes [BR:br08332]
 Antidiabetic agent
  DG01493  GLP-1 receptor agonist
   D06404  Liraglutide
  DG02044  Hypoglycemic agent
   D06404  Liraglutide
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Secretin receptor family
   Glucagon
    GLP1R
     D06404  Liraglutide (USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D06404
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D06404
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D06404
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D06404
Other DBs
CAS: 204656-20-2
PubChem: 47208061
ChEBI: 71193
NIKKAJI: J2.404.888H

» Japanese version   » Back

  All links  
Ontology (10)   
   KEGG BRITE (10)   
Pathway (1)   
   KEGG PATHWAY (1)   
Disease (1)   
   KEGG DISEASE (1)   
Drug (1)   
   KEGG DGROUP (1)   
Chemical substance (3)   
   PubChem (1)   
   ChEBI (1)   
   NIKKAJI (1)   
Gene (2)   
   KEGG ORTHOLOGY (1)   
   KEGG GENES (1)   
All databases (18)   

Download RDF
DBGET integrated database retrieval system